- Page 1:
2006 WORLD DRUG RE
- Page 4 and 5:
The Office for <st
- Page 6 and 7:
Contents Volume I. Analysis Preface
- Page 9:
5. PRODUCTION
- Page 13 and 14:
3.1. Production: Opium/heroin 3.1.1
- Page 15 and 16:
3.1. Production: Opium/heroin Afgha
- Page 17 and 18:
3.1. Production: Opium/heroin 215
- Page 19 and 20:
3.1. Production: Opium/heroin Afgha
- Page 21 and 22:
3.1. Production: Opium/heroin Afgha
- Page 23 and 24:
3.1. Production: Opium/heroin Fact
- Page 25 and 26:
3.1. Production: Opium/heroin Myanm
- Page 27 and 28:
3.1. Production: Opium/heroin Opium
- Page 29 and 30:
3.1. Production: Opium/heroin 3.1.3
- Page 31 and 32:
3.1. Production: Opium/heroin Lao P
- Page 33 and 34:
3.1. Production: Opium/heroin Opium
- Page 35 and 36:
3.1. Production: Opium/heroin <stro
- Page 37 and 38:
3.1. Production: Opium/heroin 3.1.5
- Page 39 and 40:
3.1. Production: Opium/heroin 3.2.
- Page 41 and 42:
3.2. Production : Coca/Cocaine 3.2.
- Page 43 and 44:
3.2. Production : Coca/Cocaine Colo
- Page 45 and 46:
3.2. Production : Coca/Cocaine 243
- Page 47 and 48:
3.2. Production : Coca/Cocaine Colo
- Page 49 and 50:
3.2. Production : Coca/Cocaine Fact
- Page 51 and 52:
3.2. Production : Coca/Cocaine 249
- Page 53 and 54:
3.2. Production : Coca/Cocaine Peru
- Page 55 and 56:
3.2. Production : Coca/Cocaine 3.2.
- Page 57 and 58:
3.2. Production : Coca/Cocaine Boli
- Page 59 and 60:
3.2. Production : Coca/Cocaine Boli
- Page 61 and 62:
3.2. Production : Coca/Cocaine 3.2.
- Page 63 and 64:
3.3. Production: Cannabis 3.3. Cann
- Page 65 and 66:
3.3. Production: Cannabis 263
- Page 67 and 68:
3.4.. Production: Amphetamine-type
- Page 69 and 70:
3.4.. Production: Amphetamine-type
- Page 71 and 72:
3.5. Production: Other Drug
- Page 73:
3.5. Production: Other Drug
- Page 77 and 78:
4.1. Seizures: Opiates 4.1. Opiates
- Page 79 and 80:
4.1. Seizures: Opiates Region/count
- Page 81 and 82:
4.1. Seizures: Opiates Region/count
- Page 83 and 84:
4.1. Seizures: Opiates Region/count
- Page 85 and 86:
4.1. Seizures: Opiates Region/count
- Page 87 and 88:
4.1. Seizures: Opiates Region/count
- Page 89 and 90:
4.1. Seizures: Opiates Region/count
- Page 91 and 92:
4.1. Seizures: Opiates Region/count
- Page 93 and 94:
4.1. Seizures: Opiates Region/count
- Page 95 and 96:
4.1. Seizures: Opiates Region/count
- Page 97 and 98:
4.1. Seizures: Opiates Region/count
- Page 99 and 100:
4.1. Seizures: Opiates Region/count
- Page 101 and 102:
4.1. Seizures: Opiates Region/count
- Page 103 and 104:
4.2 Seizures: Cocaine Region/countr
- Page 105 and 106:
4.2 Seizures: Cocaine Region/countr
- Page 107 and 108: 4.2 Seizures: Cocaine Region/countr
- Page 109 and 110: 4.2 Seizures: Cocaine Region/countr
- Page 111 and 112: 4.3. Seizures: Cannabis 4.3. Cannab
- Page 113 and 114: 4.3. Seizures: Cannabis Region/coun
- Page 115 and 116: 4.3. Seizures: Cannabis Region/coun
- Page 117 and 118: 4.3. Seizures: Cannabis Region/coun
- Page 119 and 120: 4.3. Seizures: Cannabis Region/coun
- Page 121 and 122: 4.3. Seizures: Cannabis Region/coun
- Page 123 and 124: 4.3. Seizures: Cannabis Region/coun
- Page 125 and 126: 4.3. Seizures: Cannabis Region/coun
- Page 127 and 128: 4.3. Seizures: Cannabis Region/coun
- Page 129 and 130: 4.3. Seizures: Cannabis Region/coun
- Page 131 and 132: 4.3. Seizures: Cannabis Region/coun
- Page 133 and 134: 4.3. Seizures: Cannabis Region/coun
- Page 135 and 136: 4.3. Seizures: Cannabis Region/coun
- Page 137 and 138: 4.4. Seizures: ATS Region/country o
- Page 139 and 140: 4.4. Seizures: ATS Region/country o
- Page 141 and 142: 4.4. Seizures: ATS Region/country o
- Page 143 and 144: 4.4. Seizures: ATS Region/country o
- Page 145 and 146: 4.4. Seizures: ATS Region/country o
- Page 147 and 148: 4.4. Seizures: ATS Region/country o
- Page 149 and 150: 4.4. Seizures: ATS Region/country o
- Page 151 and 152: 4.4. Seizures: ATS Region/country o
- Page 153 and 154: 4.4. Seizures: ATS Region/country o
- Page 155 and 156: 4.4. Seizures: ATS Region/country o
- Page 157: 4.4. Seizures: ATS Region/country o
- Page 161 and 162: 4.4. Seizures: ATS Region/country o
- Page 163: 5. PRICES
- Page 166 and 167: World Drug
- Page 168 and 169: World Drug
- Page 170 and 171: World Drug
- Page 172 and 173: World Drug
- Page 174 and 175: World Drug
- Page 176 and 177: World Drug
- Page 178 and 179: World Drug
- Page 180 and 181: World Drug
- Page 182 and 183: World Drug
- Page 185 and 186: 6. Consumption 6.1. Consumption: An
- Page 187 and 188: 6. Consumption 6.1.2. Cocaine COCAI
- Page 189 and 190: 6. Consumption EUROPE CANNABIS Annu
- Page 191 and 192: 6. Consumption AMPHETAMINES Annual
- Page 193 and 194: 6. Consumption 6.2. Treatment deman
- Page 195 and 196: 6. Consumption 6.2.3. Primary drugs
- Page 197: 6. Consumption 6.2.5. Primary drugs
- Page 201 and 202: Methodology Methodology Considerabl
- Page 203 and 204: Methodology The use of the concept
- Page 205 and 206: Methodology Sources and limitations
- Page 207 and 208: Methodology substantially diverging
- Page 209 and 210:
Methodology can be assumed that the
- Page 211 and 212:
Methodology country’s participati
- Page 213 and 214:
Methodology under-estimates are, mo
- Page 215 and 216:
Methodology Number of countries & t
- Page 217 and 218:
Methodology population of the count
- Page 219 and 220:
Printed in Slovakia June 20